119 related articles for article (PubMed ID: 12384089)
1. Dynorphin modulates ocular hydrodynamics and releases atrial natriuretic peptide via activation of kappa-Opioid receptors.
Russell KR; Potter DE
Exp Eye Res; 2002 Sep; 75(3):259-70. PubMed ID: 12384089
[TBL] [Abstract][Full Text] [Related]
2. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist.
Russell KR; Wang DR; Potter DE
Exp Eye Res; 2000 May; 70(5):675-82. PubMed ID: 10870526
[TBL] [Abstract][Full Text] [Related]
3. Bremazocine increases C-type natriuretic peptide levels in aqueous humor and enhances outflow facility.
Potter DE; Russell KR; Manhiani M
J Pharmacol Exp Ther; 2004 May; 309(2):548-53. PubMed ID: 14742737
[TBL] [Abstract][Full Text] [Related]
4. Naphazoline-induced suppression of aqueous humor pressure and flow: involvement of central and peripheral alpha(2)/I(1) receptors.
Ogidigben MJ; Chu TC; Potter DE
Exp Eye Res; 2001 Mar; 72(3):331-9. PubMed ID: 11180982
[TBL] [Abstract][Full Text] [Related]
5. Contributions of adenosine receptor activation to the ocular actions of epinephrine.
Crosson CE; Petrovich M
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2054-61. PubMed ID: 10440261
[TBL] [Abstract][Full Text] [Related]
6. Ocular actions of moxonidine: a possible role for imidazoline receptors.
Ogidigben M; Chu TC; Potter DE
J Pharmacol Exp Ther; 1994 Jun; 269(3):897-904. PubMed ID: 7912282
[TBL] [Abstract][Full Text] [Related]
7. Ocular hypotensive mechanism of intravitreally injected brain natriuretic peptide in rabbit.
Takashima Y; Taniguchi T; Yoshida M; Haque MS; Yoshimura N; Honda Y
Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2671-7. PubMed ID: 8977481
[TBL] [Abstract][Full Text] [Related]
8. Elevation of atrial natriuretic peptide levels in aqueous humor of the rabbit by kappa opioid receptor agonists.
Russell KR; Moore TT; Potter DE
Neuropeptides; 2001; 35(5-6):232-7. PubMed ID: 12030807
[TBL] [Abstract][Full Text] [Related]
9. Aqueous humor dynamics in monkeys in response to the kappa opioid agonist bremazocine.
Rasmussen CA; Gabelt BT; Kaufman PL
Trans Am Ophthalmol Soc; 2007; 105():225-38; discussion 238-9. PubMed ID: 18427613
[TBL] [Abstract][Full Text] [Related]
10. Effects of topical dihydroergocristine on intraocular pressure, aqueous humor dynamics and pupil diameter in conscious rabbits. A comparative study with timolol and pilocarpine.
Santafé Oroz J; Segarra Domenech J; Garrido García M; Pablo Martínez V
Methods Find Exp Clin Pharmacol; 1991 May; 13(4):231-8. PubMed ID: 1908543
[TBL] [Abstract][Full Text] [Related]
11. Intraocular pressure lowering by S-allylmercaptocysteine in rabbits.
Chu TC; Han P; Han G; Potter DE
J Ocul Pharmacol Ther; 1999 Feb; 15(1):9-17. PubMed ID: 10048343
[TBL] [Abstract][Full Text] [Related]
12. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.
Ogidigben M; Chu TC; Potter DE
J Pharmacol Exp Ther; 1993 Nov; 267(2):822-7. PubMed ID: 7902435
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of nitric oxide in morphine-induced miosis and reduction of intraocular pressure in rabbits.
Bonfiglio V; Bucolo C; Camillieri G; Drago F
Eur J Pharmacol; 2006 Mar; 534(1-3):227-32. PubMed ID: 16516192
[TBL] [Abstract][Full Text] [Related]
14. Intraocular effects of substance P in the rabbit.
Stjernschantz J; Sears M; Stjernschantz L
Invest Ophthalmol Vis Sci; 1981 Jan; 20(1):53-60. PubMed ID: 6161102
[TBL] [Abstract][Full Text] [Related]
15. Iloprost, a stable prostacyclin analog, reduces intraocular pressure.
Hoyng PF; de Jong N
Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):470-6. PubMed ID: 2435669
[TBL] [Abstract][Full Text] [Related]
16. Ocular effects of topical administration of the phosphodiesterase III inhibitor milrinone in rabbits and cats.
Lee KC; Silver PJ; Bode DC; Gherezghiher T
Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):527-34. PubMed ID: 8309316
[TBL] [Abstract][Full Text] [Related]
17. Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation.
Moore TT; Potter DE
Exp Eye Res; 2001 Aug; 73(2):167-78. PubMed ID: 11446767
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
Vig BS; Murray TF; Aldrich JV
J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
[TBL] [Abstract][Full Text] [Related]
19. Naphazoline-induced neuroendocrine changes: increases in ANP and cGMP levels, but suppression of NE, 3H-NE, and cAMP levels in rabbit eyes.
Ogidigben MJ; Chu TC; Potter DE
Pharmacology; 2002 Jul; 65(3):155-61. PubMed ID: 12037379
[TBL] [Abstract][Full Text] [Related]
20. Ocular hypotension induced by intravitreally injected C-type natriuretic peptide.
Takashima Y; Taniguchi T; Yoshida M; Haque MS; Igaki T; Itoh H; Nakao K; Honda Y; Yoshimura N
Exp Eye Res; 1998 Jan; 66(1):89-96. PubMed ID: 9533834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
